[ad_1]
◀ Anchor ▶
Some side effects are reported to have occurred while starting the Corona 19 vaccine developed by Pfizer.
The first Astra Zeneca vaccine, to be introduced by the Korean government, is expected to delay FDA approval until the middle of next year.
First, reporter Jeon Ye-ji reported.
◀ Report ▶
The US Food and Drug Administration is deliberating to approve the emergency use of the Corona 19 vaccine developed by Pfizer and Bioentech tomorrow morning our time.
It usually takes an extra day or two for final approval, but some observers say the process will end tomorrow.
[앨릭스 에이자/미 보건복지부 장관]“We hope to vaccinate 20 million Americans by the end of this year.”
Each state is preparing delivery of the vaccine with the goal of starting vaccination as soon as possible immediately after approval for use.
[앤드루 쿠오모/미 뉴욕주지사]“It looks like a vaccine could arrive this weekend. Our state’s priority is with nursing home residents and employees.”
As more and more countries approve Pfizer vaccines, in the UK, where routine vaccinations began, two vaccinators developed allergies.
In the US clinical trial, 4 participants were reported to have a ‘Guanwasa’ facial nerve palsy symptom.
[앤서니 파우치/미 국립알레르기·전염병연구소장]“If I am a person with an allergic predisposition, an allergic reaction can occur, so be prepared to treat it.”
Pfizer said the vaccine was limited and recommended that pregnant women or teens under 16 with allergies should not get the vaccine.
Furthermore, it was revealed that the AstraZeneca vaccine, which is scheduled to be supplied to Korea, had side effects during the clinical trial and the trial was stopped.
The US media reports that drug companies have lost confidence because they did not immediately inform health authorities of the fact, and the AstraZeneca vaccine may not be approved within this year.
AstraZeneca warned: “If approval is delayed, the vaccine supply will only be available in the middle of next year and the vaccine will be less effective.”
Another pharmaceutical company, Modena, also plans to undergo an approval review on the 17th, a week later.
This is the predecessor of MBC News.
(Video editing: Kwanghee Ahn)
MBC News awaits your report 24 hours a day.
▷ Telephone 02-784-4000
▷ Email [email protected]
▷ Report from KakaoTalk @mbc
